Abstract
Overview of classification of gastroenteropancreatic and lung neuroendocrine tumours with respect to imaging, tumour markers, prognostic factors and treatment, especially chemotherapy of poorly differentiated tumours. Analysis of poorly differentiated neuroendocrine tumoursw from the Czech Neuroendocrine Registry.